EP 0952846 A1 19991103 - PROLACTIN AS A VACCINE ADJUVANT
Title (en)
PROLACTIN AS A VACCINE ADJUVANT
Title (de)
PROLACTIN ALS IMPFSTOFFADJUVANS
Title (fr)
PROLACTINE SERVANT D'ADJUVANT POUR VACCIN
Publication
Application
Priority
- US 9501866 W 19950214
- US 19635094 A 19940214
Abstract (en)
[origin: WO9521625A1] The present invention relates to a composition for enhancing the immune response of an animal to an infectious disease vaccine wherein the composition comprises prolactin. Preferably, the composition is human prolactin and the animal to be vaccinated is, as well, human. The present invention further relates to a composition for enhancing the immune response of an animal to an infectious disease vaccine wherein the composition comprises prolactin cDNA. Human prolactin cDNA is preferred.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 38/24 (2006.01); A61K 39/39 (2006.01); A61K 48/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 37/04 (2006.01); C07K 14/575 (2006.01); C12P 21/02 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP US)
A61K 31/711 (2013.01 - EP US); A61K 39/39 (2013.01 - EP US); A61K 48/00 (2013.01 - EP US); A61P 31/04 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 37/04 (2018.01 - EP); C07K 14/57554 (2013.01 - EP US); A61K 39/00 (2013.01 - EP US); A61K 2039/53 (2013.01 - EP US); A61K 2039/55516 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9521625 A1 19950817; AU 1876595 A 19950829; AU 700104 B2 19981224; CA 2183260 A1 19950817; EP 0952846 A1 19991103; EP 0952846 A4 19991103; JP H09509415 A 19970922; US 5585099 A 19961217
DOCDB simple family (application)
US 9501866 W 19950214; AU 1876595 A 19950214; CA 2183260 A 19950214; EP 95910999 A 19950214; JP 52141495 A 19950214; US 19635094 A 19940214